Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
CVIR Endovasc ; 7(1): 35, 2024 Apr 06.
Artigo em Inglês | MEDLINE | ID: mdl-38581571

RESUMO

BACKGROUND: The migration of contraceptive devices into pulmonary arteries is extremely rare, reported to be 1 in 100,000. CASE PRESENTATION: A 19-year-old female presented no sensation of a contraceptive implant in her arm which had been placed one year prior. A CT scan confirmed that the implant had migrated into the left lower segmentary pulmonary artery. After a multidisciplinary meeting, an endovascular approach was attempted. Following right femoral venous access, a 8F NeuronMax® introducer was placed into the left pulmonary artery under fluoroscopic guidance. The contraceptive device was removed using a 25-mm loop snare, with a proximal capture technique. The patient was discharged the following day, with no reported complications. CONCLUSION: In cases of contraceptive device migration, the first medical decision involves deciding between removal or 'watching and waiting'. Previous reports describe two removal options: endovascular or surgical approaches. Fourteen reports have been published, with high technical success and low rates of complications. The loop snare technique is described as the optimal technique for an endovascular approach. Due to their invasive nature, surgical approaches should be reserved for cases of endovascular removal failure, after evaluating risks and benefits.

3.
Clin Pharmacokinet ; 63(2): 211-225, 2024 02.
Artigo em Inglês | MEDLINE | ID: mdl-38169065

RESUMO

BACKGROUND: Unfractionated heparin (UFH) is commonly used during cardiac surgery with a cardiopulmonary bypass to prevent blood clotting. However, empirical administration of UFH leads to variable responses. Pharmacokinetic and pharmacodynamic modeling can be used to optimize UFH dosing and perform real-time individualization. In previous studies, many factors that could influence UFH pharmacokinetics/pharmacodynamics had not been taken into account such as hemodilution or the type of UFH. Few covariates were identified probably owing to a lack of statistical power. This study aims to address these limitations through a meta-analysis of individual data from two studies. METHODS: An individual patient data meta-analysis was conducted using data from two single-center prospective observational studies, where different UFH types were used for anticoagulation. A pharmacodynamic/pharmacodynamic model of UFH was developed using a non-linear mixed-effects approach. Time-varying covariates such as hemodilution and fluid infusions during a cardiopulmonary bypass were considered. RESULTS: Activities of UFH's anti-activated factor/anti-thrombin were best described by a two-compartment model. Unfractionated heparin clearance was influenced by body weight and the specific UFH type. Volume of distribution was influenced by body weight and pre-operative fibrinogen levels. Pharmacodynamic data followed a log-linear model, accounting for the effect of hemodilution and the pre-operative fibrinogen level. Equations were derived from the model to personalize UFH dosing based on the targeted activated clotting time level and patient covariates. CONCLUSIONS: The population model effectively characterized UFH's pharmacokinetics/pharmacodynamics in cardiopulmonary bypass patients. This meta-analysis incorporated new covariates related to UFH's pharmacokinetics/pharmacodynamics, enabling personalized dosing regimens. The proposed model holds potential for individualization using a Bayesian estimation.


Assuntos
Ponte Cardiopulmonar , Heparina , Humanos , Heparina/farmacocinética , Teorema de Bayes , Peso Corporal , Fibrinogênio , Anticoagulantes/farmacocinética , Estudos Observacionais como Assunto
4.
Ann Thorac Surg ; 106(2): 548-554, 2018 08.
Artigo em Inglês | MEDLINE | ID: mdl-29580777

RESUMO

BACKGROUND: Health-related quality of life (HRQOL) is an increasingly important issue in assessing the consequences of any surgical or medical intervention. Our study aimed to evaluate change in HRQOL 6 months after elective cardiac operations and to identify specific predictors of poor HRQOL. METHODS: In this prospective, single-center study, HRQOL was evaluated before and 6 months after the operation using the Medical Outcome Study 36-Item Short Form Health Survey questionnaire and its two components: the Physical Component Summary and the Mental Component Summary. We distinguished patients with worsening of HRQOL according to the minimal clinically important difference. All consecutive adult patients undergoing cardiac operations were included. RESULTS: The preoperative and postoperative 36-Item Short Form Health Survey questionnaires were completed by 326 patients, and 24 patients died before completing follow-up questionnaires. On the basis of the definition used, clinically significant deterioration of HRQOL was observed in 93 patients (26.6%) for the Physical Component Summary and in 99 patients (28.2%) for the Mental Component Summary. Renal replacement for acute renal failure and mechanical ventilation for longer than 48 hours were independent risk factors for Physical Component Summary and Mental Component Summary worsening or death. CONCLUSIONS: Although our study showed overall improvement of quality of life after cardiac operations, more than one-quarter of the patients manifested deterioration of HRQOL at 6 months postoperatively. The findings from this study should help clinicians to inform patients about their likely postoperative functional status and quality of life.


Assuntos
Procedimentos Cirúrgicos Cardíacos/métodos , Procedimentos Cirúrgicos Cardíacos/psicologia , Diferença Mínima Clinicamente Importante , Qualidade de Vida , Inquéritos e Questionários , Centros Médicos Acadêmicos , Adulto , Idoso , Procedimentos Cirúrgicos Cardíacos/efeitos adversos , Progressão da Doença , Procedimentos Cirúrgicos Eletivos/efeitos adversos , Procedimentos Cirúrgicos Eletivos/métodos , Feminino , Seguimentos , França , Humanos , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Análise Multivariada , Complicações Pós-Operatórias/fisiopatologia , Complicações Pós-Operatórias/cirurgia , Estudos Prospectivos , Recidiva , Medição de Risco , Fatores de Tempo
5.
J Clin Monit Comput ; 30(6): 783-789, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26939694

RESUMO

Alteration of tissue perfusion is a main contributor of organ dysfunction. In cardiac surgery, the importance of organ dysfunction is associated with worse outcome. Central venous-arterial difference in CO2 tension (ΔCO2) has been proposed as a global marker of the adequacy of tissue perfusion in shock states. We hypothesized that ΔCO2 could be increased in case of postoperative organ failure or worse outcome. In this monocentric retrospective cohort study, we retrieved, from our database, 220 consecutive patients admitted in intensive care after an elective cardiac surgery. Four time points were formed: ICU admission, and 6, 24 and 48 h after. A ΔCO2 below 6 mmHg defined the normal range values. The SOFA score, intensive care unit and hospital length of stay, hospital and 6-month mortality rate were recorded. We compared patient with low ΔCO2 (<6 mmHg) and high ΔCO2 (≥6 mmHg). We included 55 (25 %) and 165 patients in low and high ΔCO2 groups, respectively. The SOFA score, the hospital and 6 months mortality rate were higher in patients with low ΔCO2. Surprisingly, we did not find results previously published in other surgical settings. In cardiac surgery, ΔCO2 has a low predictive value of outcome.


Assuntos
Dióxido de Carbono/sangue , Procedimentos Cirúrgicos Cardíacos/métodos , Idoso , Anestesia , Artérias/fisiologia , Gasometria , Dióxido de Carbono/química , Cuidados Críticos , Procedimentos Cirúrgicos Eletivos , Feminino , Humanos , Unidades de Terapia Intensiva , Tempo de Internação , Masculino , Pessoa de Meia-Idade , Perfusão , Período Pós-Operatório , Valor Preditivo dos Testes , Estudos Prospectivos , Estudos Retrospectivos , Risco , Temperatura , Fatores de Tempo , Veias/fisiologia
6.
Chemistry ; 8(14): 3115-27, 2002 Jul 15.
Artigo em Inglês | MEDLINE | ID: mdl-12203341

RESUMO

The reduction of diazene complexes [Mo(2)Cp(2)(mu-SMe)(3)(mu-eta(2)-H-N=N-R)](+) (R=Ph (3 a); Me (3 b)) and of the hydrazido(2-) derivative [Mo(2)Cp(2)(mu-SMe)(3)[mu-eta(1)-N=N(Me)H]](+) (1 b) has been studied by cyclic voltammetry, controlled-potential electrolysis, and coulometry in THF. The electrochemical reduction of 3 a in the presence of acid leads to cleavage of the N=N bond and produces aniline and either the amido complex [Mo(2)Cp(2)(mu-SMe)(3)(mu-NH(2))] 4 or the ammine complex [Mo(2)Cp(2)(mu-SMe)(3)(NH(3))(X)] 5, depending on the initial concentration of acid (HX=HTsO or CF(3)CO(2)H). The N=N bond of the methyldiazene analogue 3 b is not cleaved under the same conditions. The ability of 3 a but not 3 b to undergo reductive cleavage of the N=N bond is attributed to electronic control of the strength of the Mo-N(R) bond by the R group. The electrochemical reduction of the methylhydrazido(2-) compound 1 b in the presence of HX also results in cleavage of the N=N bond, with formation of methylamine, 4 (or 5) and the methyldiazenido complex [Mo(2)Cp(2)(mu-SMe)(3)(mu-eta(1)-N=N-Me)]. Formation of the last of these complexes indicates that two mechanisms (N=N bond cleavage and possibly H(2) production) are operative. A pathway for the reduction of N(2) at a dinuclear site of FeMoco is proposed on the basis of these results.


Assuntos
Imidas/química , Metaloproteínas/química , Molibdênio/química , Amônia , Domínio Catalítico , Eletroquímica , Hidrogenação , Proteínas Ferro-Enxofre/química , Ligantes , Modelos Moleculares , Fixação de Nitrogênio
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...